1 ADP-dependent glucokinase controls metabolic fitness in prostate cancer progression
来源:MILITARY MED RES( P 2095-7467 E 2054-9369 ) 发表时间: 2023/12
类型:期刊论文 为本人加分:3563.188629
贡献度:共同通讯作者
2 FLNA and PGK1 are Two Potential Markers for Progression in Hepatocellular Carcinoma
来源:CELL PHYSIOL BIOCHEM( P 1015-8987 E ) 发表时间: 2011/01
类型:期刊论文 为本人加分:2738.261573
3 RNA m6A modification in prostate cancer: A new weapon for its diagnosis and therapy
来源:BBA-REV CANCER( P 0304-419X E 1879-2561 ) 发表时间: 2023/09
类型:期刊论文 为本人加分:2642.006723
贡献度:单独通讯作者
4 rAAV-delivered PTEN therapeutics for prostate cancer
来源:MOL THER NUCL ACIDS( P 2162-2531 E ) 发表时间: 2022/03
类型:期刊论文 为本人加分:2268.259775
贡献度:单独第一作者;共同通讯作者
5 Tumor antigens and immune subtypes guided mRNA vaccine development for kidney renal clear cell carci..
来源:MOL CANCER( P E 1476-4598 ) 发表时间: 2021/12
类型:期刊论文 为本人加分:2028.648172
贡献度:单独通讯作者
6 Activation of NFKB-JMJD3 signaling promotes bladder fibrosis via boosting bladder smooth muscle cell..
来源:BBA-MOL BASIS DIS( P 0925-4439 E 1879-260X ) 发表时间: 2019/09
类型:期刊论文 为本人加分:1895.024677
7 Tumor-antigens and immune landscapes identification for prostate adenocarcinoma mRNA vaccine
来源:MOL CANCER( P E 1476-4598 ) 发表时间: 2021/12
类型:期刊论文 为本人加分:1667.876786
8 Hemoglobin, albumin, lymphocyte, and platelet (HALP) score and cancer prognosis: A systematic review..
来源:INT IMMUNOPHARMACOL( P 1567-5769 E 1878-1705 ) 发表时间: 2023/01
类型:期刊论文 为本人加分:1382.341416
贡献度:共同通讯作者
9 CXCL8 in Tumor Biology and Its Implications for Clinical Translation
来源:FRONT MOL BIOSCI( P E 2296-889X ) 发表时间: 2022/03
类型:期刊论文 为本人加分:1357.900432
贡献度:共同通讯作者
10 Identification of a Novel Nomogram to Predict Progression Based on the Circadian Clock and Insights ..
来源:FRONT IMMUNOL( P 1664-3224 E ) 发表时间: 2022/01
类型:期刊论文 为本人加分:1215.381057
贡献度:共同通讯作者